Shares of IQ-AI are on the rise Tuesday morning following news that the University of Texas MD Anderson Cancer Center is the latest brain cancer centere to purchase an annual subscription of IB Clinic software.
 IB Clinic is IQ-AI's automated processing application that generates quantitative magnetic resonance (MR) perfusion images and other maps used to assess brain tumors and monitor treatment.
The installation includes IB Neuro and IB DCE software that networks within the MD Anderson IT infrastructure and outputs quantitative maps directly to their resident picture and communication system for viewing.Â
“We are very pleased that MD Anderson has adopted IB Clinic,” said Trevor Brown, CEO of IQ-AI Limited.Â
“The automated processing is ideal for high-volume centers such as this, and the quantitative capability allows direct comparison of longitudinal scans, no matter where or when the patient is scanned.”
IQ-AI shares are up 6.48% at 6.66p following the news.
Should You Invest in IQ-AI Shares?
One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It's a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now
[optin-monster slug=”p0ejbloqlwcce16kx3do”]